JP7564620B2 - カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 - Google Patents
カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 Download PDFInfo
- Publication number
- JP7564620B2 JP7564620B2 JP2019548370A JP2019548370A JP7564620B2 JP 7564620 B2 JP7564620 B2 JP 7564620B2 JP 2019548370 A JP2019548370 A JP 2019548370A JP 2019548370 A JP2019548370 A JP 2019548370A JP 7564620 B2 JP7564620 B2 JP 7564620B2
- Authority
- JP
- Japan
- Prior art keywords
- catecholamine
- patient
- glucocorticoid receptor
- gra
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Hematology (AREA)
- Obesity (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022070027A JP2022090003A (ja) | 2017-03-09 | 2022-04-21 | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 |
| JP2024053332A JP2024074854A (ja) | 2017-03-09 | 2024-03-28 | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 |
| JP2026061808A JP2026099911A (ja) | 2017-03-09 | 2026-04-03 | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762469296P | 2017-03-09 | 2017-03-09 | |
| US62/469,296 | 2017-03-09 | ||
| PCT/US2018/021592 WO2018165460A1 (en) | 2017-03-09 | 2018-03-08 | Use of glucocorticoid receptor modulators in the treatment of catecholamine-secreting tumors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022070027A Division JP2022090003A (ja) | 2017-03-09 | 2022-04-21 | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020510011A JP2020510011A (ja) | 2020-04-02 |
| JP2020510011A5 JP2020510011A5 (cg-RX-API-DMAC7.html) | 2021-02-18 |
| JP7564620B2 true JP7564620B2 (ja) | 2024-10-09 |
Family
ID=63446773
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019548370A Active JP7564620B2 (ja) | 2017-03-09 | 2018-03-08 | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 |
| JP2022070027A Withdrawn JP2022090003A (ja) | 2017-03-09 | 2022-04-21 | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 |
| JP2024053332A Withdrawn JP2024074854A (ja) | 2017-03-09 | 2024-03-28 | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 |
| JP2026061808A Pending JP2026099911A (ja) | 2017-03-09 | 2026-04-03 | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022070027A Withdrawn JP2022090003A (ja) | 2017-03-09 | 2022-04-21 | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 |
| JP2024053332A Withdrawn JP2024074854A (ja) | 2017-03-09 | 2024-03-28 | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 |
| JP2026061808A Pending JP2026099911A (ja) | 2017-03-09 | 2026-04-03 | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11045482B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3592358A4 (cg-RX-API-DMAC7.html) |
| JP (4) | JP7564620B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN110475558A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018230429B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3053806A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2019010732A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018165460A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021007402A (es) | 2018-12-20 | 2021-07-15 | Corcept Therapeutics Inc | Metodos para la toma de imagenes y el tratamiento de tumores positivos para el receptor de somatostatina. |
| JP2021079146A (ja) * | 2021-02-22 | 2021-05-27 | 株式会社三洋物産 | 遊技機 |
| JP7315071B2 (ja) * | 2021-03-03 | 2023-07-26 | 株式会社三洋物産 | 遊技機 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013039916A1 (en) | 2011-09-12 | 2013-03-21 | The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services | Compositions for and methods of treatment and enhanced detection of non-pituitary tumors |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9606736D0 (en) | 1996-02-19 | 1996-06-05 | Shire International Licensing | Therapeutic method |
| CA2246791A1 (en) | 1998-09-01 | 2000-03-01 | Alison Buchan | Treatment of endothelium with somatostatin analogues |
| US6818739B2 (en) | 1999-12-03 | 2004-11-16 | Ndsu Research Foundation | Somatostatins |
| US6139845A (en) | 1999-12-07 | 2000-10-31 | Allergan Sales, Inc. | Method for treating cancer with a neurotoxin |
| JP2004525135A (ja) | 2001-03-23 | 2004-08-19 | コーセプト セラピューティクス, インコーポレイテッド | 糖質コルチコイドレセプター特異的アンタゴニストを使用するストレス障害を処置するための方法 |
| WO2003057214A1 (en) | 2001-12-28 | 2003-07-17 | Somatocor Pharmaceuticals, Inc. | Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands |
| RU28362U1 (ru) | 2002-12-10 | 2003-03-20 | Закрытое акционерное общество "Дальневосточная технология" | Лист заходной футеровки |
| JP4931794B2 (ja) | 2004-03-09 | 2012-05-16 | コーセプト セラピューティクス, インコーポレイテッド | 縮合環アザデカリン糖質コルチコイド受容体モジュレーター |
| GB0428151D0 (en) * | 2004-12-22 | 2005-01-26 | Novartis Ag | Organic compounds |
| EP2145186A4 (en) * | 2007-05-15 | 2010-10-20 | Water Technologies Corp | DEVICE AND METHOD FOR THE DETECTION OF METANEPHRINES IN PLASMA |
| EP2532350A1 (en) | 2007-10-17 | 2012-12-12 | Laboratoire HRA Pharma | Pharmaceutical combination of a glucocorticoid receptor antagonist and a cortisol synthesis inhibitor for treating cushing's syndrome |
| ES2351569B8 (es) | 2009-05-07 | 2012-06-20 | Bcn Peptides S.A. | Ligandos peptídicos de receptores de somatostatina. |
| AU2010247766B2 (en) | 2009-05-12 | 2015-05-21 | Corcept Therapeutics, Inc. | Solid forms and process for preparing |
| WO2011094814A1 (en) * | 2010-02-05 | 2011-08-11 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
| CN103596431B (zh) | 2011-03-18 | 2016-06-22 | 科赛普特治疗公司 | 嘧啶环己基糖皮质激素受体调节剂 |
| US8859774B2 (en) | 2012-05-25 | 2014-10-14 | Corcept Therapeutics, Inc. | Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators |
| ES2943542T3 (es) | 2013-11-25 | 2023-06-14 | Corcept Therapeutics Inc | Moduladores del receptor de glucocorticoides de azadecalina condensada con octahidro |
| JP6821582B2 (ja) * | 2015-03-02 | 2021-01-27 | コーセプト セラピューティクス, インコーポレイテッド | Acth分泌腫瘍を処置するための糖質コルチコイドレセプターアンタゴニストおよびソマトスタチンアナログの使用 |
| US9943526B2 (en) * | 2015-04-21 | 2018-04-17 | Corcept Therapeutics, Inc. | Optimizing mifepristone levels for cushing's patients |
-
2018
- 2018-03-08 CA CA3053806A patent/CA3053806A1/en active Pending
- 2018-03-08 CN CN201880015928.3A patent/CN110475558A/zh active Pending
- 2018-03-08 WO PCT/US2018/021592 patent/WO2018165460A1/en not_active Ceased
- 2018-03-08 US US15/915,284 patent/US11045482B2/en active Active
- 2018-03-08 AU AU2018230429A patent/AU2018230429B2/en active Active
- 2018-03-08 EP EP18763240.1A patent/EP3592358A4/en active Pending
- 2018-03-08 MX MX2019010732A patent/MX2019010732A/es unknown
- 2018-03-08 JP JP2019548370A patent/JP7564620B2/ja active Active
-
2022
- 2022-04-21 JP JP2022070027A patent/JP2022090003A/ja not_active Withdrawn
-
2024
- 2024-03-28 JP JP2024053332A patent/JP2024074854A/ja not_active Withdrawn
-
2026
- 2026-04-03 JP JP2026061808A patent/JP2026099911A/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013039916A1 (en) | 2011-09-12 | 2013-03-21 | The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services | Compositions for and methods of treatment and enhanced detection of non-pituitary tumors |
Non-Patent Citations (1)
| Title |
|---|
| CLINICAL OBSTETRICS AND GYNECOLOGY,1996年,Vol.39,No.2,pp.506-510 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN110475558A (zh) | 2019-11-19 |
| US20180256604A1 (en) | 2018-09-13 |
| CA3053806A1 (en) | 2018-09-13 |
| JP2024074854A (ja) | 2024-05-31 |
| WO2018165460A1 (en) | 2018-09-13 |
| EP3592358A1 (en) | 2020-01-15 |
| JP2020510011A (ja) | 2020-04-02 |
| EP3592358A4 (en) | 2020-12-16 |
| US11045482B2 (en) | 2021-06-29 |
| AU2018230429B2 (en) | 2023-06-15 |
| JP2022090003A (ja) | 2022-06-16 |
| JP2026099911A (ja) | 2026-06-18 |
| MX2019010732A (es) | 2019-11-01 |
| AU2018230429A1 (en) | 2019-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11073523B2 (en) | Method for differentially diagnosing ACTH-dependent Cushing's syndrome | |
| JP6821582B2 (ja) | Acth分泌腫瘍を処置するための糖質コルチコイドレセプターアンタゴニストおよびソマトスタチンアナログの使用 | |
| JP2024074854A (ja) | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 | |
| CA2978960C (en) | Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency | |
| JP2022164775A (ja) | 選択的グルココルチコイドレセプターモジュレーターを使用して神経上皮腫瘍を処置する方法 | |
| JP2023052618A (ja) | 糖質コルチコイド受容体モジュレータおよびcyp3aインヒビタの併用投与 | |
| HK1255714B (en) | Method for differentially diagnosing acth-dependent cushing's syndrome |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210107 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210107 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220202 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220421 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20220818 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221219 |
|
| C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20221219 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20221227 |
|
| C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20221228 |
|
| A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20230203 |
|
| C211 | Notice of termination of reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C211 Effective date: 20230207 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240806 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240927 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7564620 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |